• 2005

Company Description

Cerenis Therapeutics is a biotechnology company involved in the R&D of HDL therapies for cardiovascular and metabolic diseases.

Cerenis Therapeutics is a multinational biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases.